Stanowisko ekspertów Polskiego Towarzystwa Kardiologicznego dotyczące celów terapeutycznych w zakresie stężeń cholesterolu frakcji LDL w prewencji wtórnej …
P Mitkowski, A Witkowski, J Stępińska… - Polish Heart …, 2023 - journals.viamedica.pl
Choroby układu sercowo-naczyniowego stanowią przyczynę 43% zgonów w Polsce.
Pandemia COVID-1 9 zwiększyła liczbę zgonów z przyczyn sercowo-naczyniowych aż o 16 …
Pandemia COVID-1 9 zwiększyła liczbę zgonów z przyczyn sercowo-naczyniowych aż o 16 …
Position of the Polish Cardiac Society on therapeutic targets for LDL cholesterol concentrations in secondary prevention of myocardial infarctions
P Mitkowski, A Witkowski, J Stępińska… - Kardiologia Polska …, 2023 - journals.viamedica.pl
Cardiovascular diseases account for 43% of deaths in Poland. The COVID-1 9 pandemic
increased the number of cardiovascular deaths by as much as 16.7%. Lipid metabolism …
increased the number of cardiovascular deaths by as much as 16.7%. Lipid metabolism …
Terapia hipercholesterolemii w schorzeniach układu sercowo-naczyniowego—jaki cel, jaka statyna, jaka dawka?
B Wożakowska-Kapłon - Folia Cardiologica, 2014 - journals.viamedica.pl
Podstawowym celem terapii hipolipemizującej jest cholesterol frakcji LDL (LDL-C). U
chorych z grupy bardzo dużego ryzyka sercowo-naczyniowego (rozpoznana choroba …
chorych z grupy bardzo dużego ryzyka sercowo-naczyniowego (rozpoznana choroba …
Achieving the unachievable: How to optimize lipid-lowering therapy in survivors of acute myocardial infarction
D Atar, A Bakken… - Polish Heart Journal …, 2023 - journals.viamedica.pl
The causal role of elevated levels of low-density lipoprotein cholesterol (LDL-C) in the
development and progression of atherosclerotic cardiovascular disease (ASCVD) is well …
development and progression of atherosclerotic cardiovascular disease (ASCVD) is well …
Eliminate LDL cholesterol after heart attack… but only for a while
F Prati, FG Biccirè, E Sammartini… - European Heart Journal …, 2024 - academic.oup.com
There is a clear demonstration of the inverse linear correlation between LDL cholesterol
levels and clinical benefit. However, the timing of the action of lipid-lowering drugs is not …
levels and clinical benefit. However, the timing of the action of lipid-lowering drugs is not …
Benefits of early lipid-lowering intervention in high-risk patients: the lipid intervention strategies for coronary patients study
TR Pedersen, KE Jahnsen, S Vatn, AG Semb… - Clinical …, 2000 - Elsevier
BACKGROUND: There is controversy about whether lipid-lowering pharmacotherapy should
be initiated immediately after an acute coronary event or only after diet and lifestyle changes …
be initiated immediately after an acute coronary event or only after diet and lifestyle changes …
Outcomes of lipid control in secondary prevention of coronary artery disease in Finland: a 24-month follow-up after acute coronary syndrome
RL Leskelä, A Torvinen, TT Rissanen, V Virtanen… - Atherosclerosis, 2020 - Elsevier
Background and aims Ischemic heart diseases are the main cause of death worldwide,
therefore secondary prevention and treatment of coronary artery disease (CAD) are highly …
therefore secondary prevention and treatment of coronary artery disease (CAD) are highly …
Nakolik jsme schopni dosáhnout současně platných cílových hodnot LDL-cholesterolu v sekundární prevenci ischemické choroby srdeční
O Mayer, J Bruthans - Vnitřní lékařství, 2015 - casopisvnitrnilekarstvi.cz
Background: A number of clinical trials have shown that patients with overt atherovascular
disease may benefit from more aggressive dosage of statins. We aimed to determined the …
disease may benefit from more aggressive dosage of statins. We aimed to determined the …
[PDF][PDF] Predictive value of selected lipid parameters among patients with acute myocardial infarction
D Drwiła-Stec - 2023 - ruj.uj.edu.pl
Ocena ryzyka sercowo-naczyniowego oraz jego redukcja są jednymi z filarów postępowania
zarówno w prewencji pierwotnej jak i wtórnej we współczesnej kardiologii zachowawczej …
zarówno w prewencji pierwotnej jak i wtórnej we współczesnej kardiologii zachowawczej …
Complex lipid-lowering treatment options in patients with a history of acute coronary syndrome
G Dani, L Márk, A Katona - Orvosi Hetilap, 2011 - akjournals.com
Authors aimed to assess how target values in serum lipid concentrations (LDL-and HDL-
cholesterol, triglyceride) can be achieved in patients with a history of acute coronary …
cholesterol, triglyceride) can be achieved in patients with a history of acute coronary …